T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.62B |
| 2 |
Ingersoll Rand
IR
|
+$2.99B |
| 3 |
Fortive
FTV
|
+$2.58B |
| 4 |
Apple
AAPL
|
+$2.46B |
| 5 |
Yum! Brands
YUM
|
+$2.1B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Healthcare | 21.85% |
| 3 | Financials | 13.14% |
| 4 | Consumer Discretionary | 12.07% |
| 5 | Industrials | 11.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Coastal Financial
CCB
$790M
| $24.2M | 0.02% |
+609,085
| New | +$24.6M |
|
427
Columbia Financial
CLBK
$1.21B
| $24.1M | 0.02% |
+1,138,214
| New | +$24.6M |
|
|
RXDX
428
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $24M | 0.02% |
+407,251
| New | +$18.6M |
|
|
PVBC
429
DELISTED
Provident Bancorp
PVBC
| $24M | 0.02% |
+1,674,219
| New | +$24.9M |
|
430
Dutch Bros
BROS
$9.12B
| $23.7M | 0.02% |
+760,076
| New | +$28.6M |
|
|
POSH
431
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $23.5M | 0.02% |
+1,498,391
| New | +$17.9M |
|
432
Packaging Corp of America
PKG
$22.8B
| $23.3M | 0.02% |
+207,736
| New | +$28.1M |
|
433
PROG Holdings
PRG
$1.67B
| $23.3M | 0.02% |
+1,553,298
| New | +$29.2M |
|
434
Ponce Financial Group
PDLB
$501M
| $23.1M | 0.02% |
+2,516,489
| New | +$23.5M |
|
435
Knowles
KN
$3.32B
| $23M | 0.02% |
+1,891,714
| New | +$30.3M |
|
|
HIBB
436
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $22.7M | 0.02% |
+455,479
| New | +$23.9M |
|
437
Syndax Pharmaceuticals
SNDX
$1.74B
| $22.2M | 0.02% |
+923,226
| New | +$20.7M |
|
438
NeoGenomics
NEO
$2.12B
| $22.1M | 0.02% |
+2,568,909
| New | +$25.5M |
|
|
AIV
439
Aimco
AIV
$382M
| $21.9M | 0.02% |
+2,993,517
| New | +$24.6M |
|
440
Conduent
CNDT
$238M
| $21.8M | 0.02% |
+6,527,418
| New | +$27.2M |
|
|
RPTX
441
DELISTED
Repare Therapeutics
RPTX
| $21.4M | 0.02% |
+1,762,743
| New | +$22.7M |
|
442
Replimune Group
REPL
$1.44B
| $21.2M | 0.02% |
+1,226,870
| New | +$23.4M |
|
443
FS Bancorp
FSBW
$324M
| $21.2M | 0.02% |
+776,514
| New | +$22.7M |
|
|
MORF
444
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $20.7M | 0.02% |
+733,064
| New | +$20.4M |
|
|
OLK
445
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $20.5M | 0.02% |
+1,690,755
| New | +$25.9M |
|
446
Main Street Capital
MAIN
$5.52B
| $19.8M | 0.02% |
+589,109
| New | +$24.3M |
|
447
Atmos Energy
ATO
$28.9B
| $19.8M | 0.02% |
+194,174
| New | +$22.2M |
|
448
Definitive Healthcare
DH
$69.8M
| $19.7M | 0.02% |
+1,268,951
| New | +$27.9M |
|
|
OLPX
449
DELISTED
Olaplex Holdings
OLPX
| $19.6M | 0.02% |
+2,057,274
| New | +$29.5M |
|
|
SNCY
450
DELISTED
Sun Country Airlines
SNCY
| $19.5M | 0.02% |
+1,431,294
| New | +$26.8M |
|
Similar funds
T. Rowe Price Investment Management's Q3 2022 Portfolio in Review
Q3 2022 is the first quarter with a 13F filing on record for T. Rowe Price Investment Management, which disclosed 541 positions worth $125B. Its ten largest holdings account for 18% of the portfolio.
Its largest position is Microsoft: 17,509,233 shares worth $4.08B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, followed by Healthcare and Financials.
- T. Rowe Price Investment Management's largest Q3 2022 buy was Microsoft: 17,509,233 shares worth $4.08B.
- T. Rowe Price Investment Management's ten largest holdings make up 18% of its $125B portfolio in Q3 2022.
- T. Rowe Price Investment Management disclosed 541 positions in Q3 2022, its first 13F filing on record.
Based on T. Rowe Price Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.